Prostate cancer Flashcards
What is prostrate cancer?
Prostate cancer is a malignant tumour that arises from the cells of the prostate, a small walnut-sized gland that produces seminal fluid in men
What are the risk factors for prostrate cancer?
- Age > 50
- Afro-Caribbean
- Family history - BRCA:
BRCA 1 and 2 (breast cancer gene 1 & 2) are non modifiable risk factors more commonly associated with breast and ovarian cancer. However, male carriers are at higher risk of prostate (and breast) cancer - Dietary factors
- Occupational exposure to cadmium (by-product of zinc production)
What are the presenting symptoms of prostrate cancer?
- Typically asymptomatic, until it progresses:
- Urinary symptoms, including difficulty initiating or stopping urination
- Poor urine stream
- Haematospermia (blood in semen)
- Pelvic discomfort
- Bone pain, potentially indicating metastatic disease
- Erectile dysfunction
What signs of prostrate cancer can be found on physical examination?
Abnormal DRE → asymmetrical, hard, nodular enlargement of prostate, with loss of midline sulcus
What investigations are used to diagnose/ monitor prostrate cancer?
- Transrectal ultrasound-guided needle biopsy → gold standard. May detect adenocarcinoma. Gleason staging.
- Multiparametric MRI is now 1st line investigation - PSA Levels → not cancer-specific however, as levels may also be elevated in benign conditions (BPH, UTI, prostitis). PSA>4 ng/mL: prostate cancer is likely.
- DRE
- Bone Scan → check for metastases (raised ALP if bone mets)
- Pelvic CT/MRI Scan → can help stage cancer
- MRI Spine - look for metastases causing spinal cord compression (can lead to incontinence and weakness) - Gleason Grading System (Low Gleason Score = better prognosis)
How is prostrate cancer managed?
- Localised Prostate Cancer (Low Grade) → active monitoring and watchful waiting
- Localised Advanced Prostate Cancer (T3/T4) → radical prostatectomy (ED is a common complication)/ robotically assisted laparoscopic prostatectomy (RALP) Radiotherapy.
- Can also cause urethral stricture that can cause LUTS (incontinence). - Metastatic Prostate Cancer → hormonal therapy-aim to reduce testosterone levels, slowing the progression of metastatic prostate cancer
- GnRH agonists - goserelin
*Side Effects = gynaecomastia, decreased libido, impotence, infertility
- Androgen antagonists ⇒ bicalutamide and enzalutamide
- GnRH antagonists ⇒ degarelix
Describe the prognosis behind prostrate cancer
Prostate cancer is a curable cancer. Biochemical disease-free survival and overall survival depend on initial stage of disease at the time of diagnosis.
Describe the epidemiology of prostrate cancer
2nd most common cancer& 5th leading cause of cancer mortality in men worldwide